Drug Information
Generic/working name	Avelumab
Company name	EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA
Drug type	Monolonal antibody
Drug class	Anti-PD-L1 monoclonal antibody
Dose	10
Unit	mg kg−1
Route	IV
Schedule of administration	Every 2 weeks